Henry O. Gosebruch
President & CEO at Neumora Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 2 boards, counting each seat separately. Longest: Neumora Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Neumora Therapeutics Inc. June 13, 202497.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 19, 2026 | ANI Pharmaceuticals Inc. | Grant or award | +6,662 | — | — |
| Feb 14, 2024 | Neumora Therapeutics Inc. | Grant or award | +80,000 | — | — |
| Sep 19, 2023 | Neumora Therapeutics Inc. | Open-market purchase | +15,000 | $12.62 | $189,300 |
Questions about Henry O. Gosebruch
What boards is Henry O. Gosebruch on?
Henry O. Gosebruch sits on the boards of ANI Pharmaceuticals Inc. and Neumora Therapeutics Inc.
What company is Henry O. Gosebruch the CEO of?
Henry O. Gosebruch has been President & CEO of Neumora Therapeutics Inc. since September 2023.
How long has Henry O. Gosebruch served on boards?
Our records show at least 3 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.